Brain-Invading breast cancer targeted with direct spinal fluid treatment
NCT ID NCT04588545
Summary
This study is testing whether radiation therapy followed by two targeted cancer drugs delivered directly into the spinal fluid is safe and can help people live longer. It's for patients with HER2-positive breast cancer that has spread to the lining of the brain and spinal cord. The goal is to control this aggressive form of cancer that is difficult to treat with standard medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Northwestern University
RECRUITINGEvanston, Illinois, 60208, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.